(Q53331062)

English

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

scientific article published in November 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Jacques Van Dongen

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A Biondi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M G Valsecchi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Seriu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E D'Aniello

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M J Willemse

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Fasching

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Pannunzio

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Gadner

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Schrappe

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

W A Kamps

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C R Bartram

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E R Panzer-Grümayer

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1939-1943

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11069029%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoreduction and prognosis in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401922

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53331062&oldid=2212080016"